RITESH INTERNATIONAL LTD.
RITESHIN (BSE 519097) · ISIN INE534D01014 · Commodity Chemicals · Est. 1981 · listed 2001 · website
In Q2 FY27 (quarter to 30 September 2026, standalone), revenue was ₹70.34 cr and profit after tax ₹3.08 cr. Revenue was 81.6% higher than in Q2 FY26.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY27 standalone | ₹70.34 cr | ₹3.08 cr | 3.28 | 21 Oct 2026 |
| Q1 FY27 standalone | ₹50.54 cr | ₹1.74 cr | 1.86 | 27 Jul 2026 |
| Q4 FY26 standalone | ₹48.75 cr | ₹1.05 cr | 1.21 | 21 May 2026 |
| Q3 FY26 standalone | ₹44.46 cr | ₹1.19 cr | 1.39 | 30 Jan 2026 |
| Q2 FY26 standalone | ₹38.74 cr | ₹1.06 cr | 1.24 | 10 Nov 2025 |
| Q4 FY25 standalone | ₹37.62 cr | ₹2.02 cr | 2.36 | 21 May 2025 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 30 Sep 2026 standalone | ₹34.79 cr | ₹16.37 cr | ₹62.13 cr |
| 31 Mar 2026 standalone | ₹29.97 cr | ₹8.92 cr | ₹47.92 cr |
| 30 Sep 2025 standalone | ₹24.03 cr | ₹10.62 cr | ₹41.58 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 48.03% | — | 0.06% | 51.97% |
Latest filings
- Annual Report FY2025-26 (New) 2 September 2026 · BSE
- Financial Results for the Quarter ended 30th June 2026 27 July 2026 · BSE
- Results for the quarter and year ended 31.03.2026 21 May 2026 · BSE
- Financial Results for the Quarter ended 31.12.2025 30 January 2026 · BSE
- Financial Results for Quarter/Half Year ended 30.09.2025 10 November 2025 · BSE
Other companies in Commodity Chemicals
- Deepak Fertilizers and Petrochemicals Corporation Limited
- POCL Enterprises Limited
- Thirumalai Chemicals Limited
- Jocil Limited
- Transpek Industry Limited
- OCCL Limited
- HINDUSTAN ORGANIC CHEMICALS LT
- Lords Chloro Alkali Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 21 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.